
Joseph M. Collaco, MD, PhD
Advertisement
Articles by Joseph M. Collaco, MD, PhD


Current prevention strategies include 2 injectables for infants and young children, namely palivizumab and nirsevimab.

Flovent was discontinued in January 2024 due to the manufacturer electing to produce only an authorized generic version of the medication.

An overview of commercially available infant cardiorespiratory monitors and pulse oximeters in the home.

Supplemental oxygen can be delivered safely to patients in their home. Here experts discuss the indications for oxygen therapy, the amount needed, and the interface for delivery.
Advertisement
Latest Updated Articles
CPAP/bilevel PAP in the home settingAugust 29th 2025
Oxygen delivery in the home settingSeptember 6th 2019
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Pediatric clinical trials update: May 2026
2
Simple screening questions may help pediatricians identify hidradenitis suppurativa earlier
3
Jamie Wood, MD, on the significance of the Afrezza approval for pediatric diabetes
4
How to recognize and when to refer for children with hidradenitis suppurativa
5
